ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 254 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2022. The put-call ratio across all filers is 8.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $239,728 | -17.7% | 19,026 | -14.8% | 0.01% | -25.0% |
| Q1 2023 | $291,315 | -81.5% | 22,323 | -78.4% | 0.01% | -80.6% |
| Q3 2022 | $1,574,000 | +26.0% | 103,312 | +22.7% | 0.06% | +14.8% |
| Q2 2022 | $1,249,000 | +304.2% | 84,226 | +404.6% | 0.05% | +80.0% |
| Q2 2021 | $309,000 | – | 16,693 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |